Aerosolized Dornase Alfa (DNase I) for the Treatment of Severe Respiratory Failure in COVID-19: A Randomized Controlled Trial

• by Per Åkesson, Lisa Mellhammar, Magnus Rasmussen, Malin Inghammar, Sara Jesperson, Fredrik Månsson, Elin Economou Lundeberg, John Walles, Martin Wallberg, Attila Frigyesi, Adam Linder

• April 24, 2025

COVID-19, Vaccines, and Retinal Vascular Disease

A global systematic review of 173 studies found differing associations between COVID-19 infection and vaccination and retinal vascular events, with retinal artery occlusion more common after infection and retinal vein occlusion more common after vaccination.

• by Nirojini Sivachandran, MD, PhD, FRCSC

• May 14, 2026

• 2 min

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave

• by Zhang, Hangjie , Yin, Haichang , Bao, Ruijing , Ma, Lanxin , Dai, RongRong , Liu, Xinyu , Xu, Nani , He, Fang , Jiang, Jianmin

• May 18, 2026

Early ICU Rehab Backed, With Caveats

Invited narrative review supports early, interprofessional rehabilitation across the ICU recovery continuum while emphasizing heterogeneous evidence and inconsistent implementation worldwide.

• by Andrea Surnit

• May 11, 2026

• 8 min